Table of Content

1 Genetic Engineering Drug Market Overview
1.1 Product Overview and Scope of Genetic Engineering Drug
1.2 Genetic Engineering Drug Segment by Type
1.2.1 Global Genetic Engineering Drug Market Value Comparison by Type (2024-2034)
1.2.2 Monoclonal Antibody
1.2.3 Recombinant Human Erythropoietin
1.2.4 Recombinant Human Interferon
1.2.5 Recombinant Human Growth Hormone
1.2.6 Recombinant Human Insulin
1.3 Genetic Engineering Drug Segment by Application
1.3.1 Global Genetic Engineering Drug Market Value by Application: (2024-2034)
1.3.2 Medicine
1.3.3 Research
1.3.4 Industrial
1.3.5 Agriculture
1.3.6 Other
1.4 Global Genetic Engineering Drug Market Size Estimates and Forecasts
1.4.1 Global Genetic Engineering Drug Revenue 2018-2029
1.4.2 Global Genetic Engineering Drug Sales 2018-2029
1.4.3 Global Genetic Engineering Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Genetic Engineering Drug Market Competition by Manufacturers
2.1 Global Genetic Engineering Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Genetic Engineering Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Genetic Engineering Drug Average Price by Manufacturers (2018-2024)
2.4 Global Genetic Engineering Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Genetic Engineering Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetic Engineering Drug, Product Type & Application
2.7 Genetic Engineering Drug Market Competitive Situation and Trends
2.7.1 Genetic Engineering Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genetic Engineering Drug Players Market Share by Revenue
2.7.3 Global Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genetic Engineering Drug Retrospective Market Scenario by Region
3.1 Global Genetic Engineering Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Genetic Engineering Drug Global Genetic Engineering Drug Sales by Region: 2018-2029
3.2.1 Global Genetic Engineering Drug Sales by Region: 2018-2024
3.2.2 Global Genetic Engineering Drug Sales by Region: 2024-2029
3.3 Global Genetic Engineering Drug Global Genetic Engineering Drug Revenue by Region: 2018-2029
3.3.1 Global Genetic Engineering Drug Revenue by Region: 2018-2024
3.3.2 Global Genetic Engineering Drug Revenue by Region: 2024-2029
3.4 North America Genetic Engineering Drug Market Facts & Figures by Country
3.4.1 North America Genetic Engineering Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Genetic Engineering Drug Sales by Country (2018-2029)
3.4.3 North America Genetic Engineering Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Genetic Engineering Drug Market Facts & Figures by Country
3.5.1 Europe Genetic Engineering Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Genetic Engineering Drug Sales by Country (2018-2029)
3.5.3 Europe Genetic Engineering Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genetic Engineering Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Genetic Engineering Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Genetic Engineering Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Genetic Engineering Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Genetic Engineering Drug Market Facts & Figures by Country
3.7.1 Latin America Genetic Engineering Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Genetic Engineering Drug Sales by Country (2018-2029)
3.7.3 Latin America Genetic Engineering Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetic Engineering Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Genetic Engineering Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Genetic Engineering Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Genetic Engineering Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Genetic Engineering Drug Sales by Type (2018-2029)
4.1.1 Global Genetic Engineering Drug Sales by Type (2018-2024)
4.1.2 Global Genetic Engineering Drug Sales by Type (2024-2029)
4.1.3 Global Genetic Engineering Drug Sales Market Share by Type (2018-2029)
4.2 Global Genetic Engineering Drug Revenue by Type (2018-2029)
4.2.1 Global Genetic Engineering Drug Revenue by Type (2018-2024)
4.2.2 Global Genetic Engineering Drug Revenue by Type (2024-2029)
4.2.3 Global Genetic Engineering Drug Revenue Market Share by Type (2018-2029)
4.3 Global Genetic Engineering Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Genetic Engineering Drug Sales by Application (2018-2029)
5.1.1 Global Genetic Engineering Drug Sales by Application (2018-2024)
5.1.2 Global Genetic Engineering Drug Sales by Application (2024-2029)
5.1.3 Global Genetic Engineering Drug Sales Market Share by Application (2018-2029)
5.2 Global Genetic Engineering Drug Revenue by Application (2018-2029)
5.2.1 Global Genetic Engineering Drug Revenue by Application (2018-2024)
5.2.2 Global Genetic Engineering Drug Revenue by Application (2024-2029)
5.2.3 Global Genetic Engineering Drug Revenue Market Share by Application (2018-2029)
5.3 Global Genetic Engineering Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Shanghai Lansheng Guojian Pharmaceutical
6.1.1 Shanghai Lansheng Guojian Pharmaceutical Corporation Information
6.1.2 Shanghai Lansheng Guojian Pharmaceutical Description and Business Overview
6.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolio
6.1.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments/Updates
6.2 Biotech Pharmaceutical
6.2.1 Biotech Pharmaceutical Corporation Information
6.2.2 Biotech Pharmaceutical Description and Business Overview
6.2.3 Biotech Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Biotech Pharmaceutical Genetic Engineering Drug Product Portfolio
6.2.5 Biotech Pharmaceutical Recent Developments/Updates
6.3 Anhui Anke Biotechnology
6.3.1 Anhui Anke Biotechnology Corporation Information
6.3.2 Anhui Anke Biotechnology Description and Business Overview
6.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolio
6.3.5 Anhui Anke Biotechnology Recent Developments/Updates
6.4 GeneScience Pharmaceuticals
6.4.1 GeneScience Pharmaceuticals Corporation Information
6.4.2 GeneScience Pharmaceuticals Description and Business Overview
6.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolio
6.4.5 GeneScience Pharmaceuticals Recent Developments/Updates
6.5 Beijing SL Pharmaceutical
6.5.1 Beijing SL Pharmaceutical Corporation Information
6.5.2 Beijing SL Pharmaceutical Description and Business Overview
6.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolio
6.5.5 Beijing SL Pharmaceutical Recent Developments/Updates
6.6 Jiangsu Sihuan Bioengineering
6.6.1 Jiangsu Sihuan Bioengineering Corporation Information
6.6.2 Jiangsu Sihuan Bioengineering Description and Business Overview
6.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolio
6.6.5 Jiangsu Sihuan Bioengineering Recent Developments/Updates
6.7 Shenzhen Neptunus Interlong Bio-Technique
6.6.1 Shenzhen Neptunus Interlong Bio-Technique Corporation Information
6.6.2 Shenzhen Neptunus Interlong Bio-Technique Description and Business Overview
6.6.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolio
6.7.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments/Updates
6.8 3SBio
6.8.1 3SBio Corporation Information
6.8.2 3SBio Description and Business Overview
6.8.3 3SBio Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 3SBio Genetic Engineering Drug Product Portfolio
6.8.5 3SBio Recent Developments/Updates
6.9 Tonghua Dongbao Pharmaceutical
6.9.1 Tonghua Dongbao Pharmaceutical Corporation Information
6.9.2 Tonghua Dongbao Pharmaceutical Description and Business Overview
6.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolio
6.9.5 Tonghua Dongbao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetic Engineering Drug Industry Chain Analysis
7.2 Genetic Engineering Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetic Engineering Drug Production Mode & Process
7.4 Genetic Engineering Drug Sales and Marketing
7.4.1 Genetic Engineering Drug Sales Channels
7.4.2 Genetic Engineering Drug Distributors
7.5 Genetic Engineering Drug Customers
8 Genetic Engineering Drug Market Dynamics
8.1 Genetic Engineering Drug Industry Trends
8.2 Genetic Engineering Drug Market Drivers
8.3 Genetic Engineering Drug Market Challenges
8.4 Genetic Engineering Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Genetic Engineering Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Genetic Engineering Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Genetic Engineering Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Genetic Engineering Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Genetic Engineering Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Genetic Engineering Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Genetic Engineering Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Genetic Engineering Drug Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Genetic Engineering Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Genetic Engineering Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Genetic Engineering Drug, Product Type & Application
Table 12. Global Key Manufacturers of Genetic Engineering Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Genetic Engineering Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Engineering Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Genetic Engineering Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Genetic Engineering Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global Genetic Engineering Drug Sales Market Share by Region (2018-2024)
Table 19. Global Genetic Engineering Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Genetic Engineering Drug Sales Market Share by Region (2024-2029)
Table 21. Global Genetic Engineering Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Genetic Engineering Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Genetic Engineering Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Genetic Engineering Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Genetic Engineering Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America Genetic Engineering Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Genetic Engineering Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Genetic Engineering Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Genetic Engineering Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe Genetic Engineering Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Genetic Engineering Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Genetic Engineering Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Genetic Engineering Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Genetic Engineering Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Genetic Engineering Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Genetic Engineering Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Genetic Engineering Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Genetic Engineering Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Genetic Engineering Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Genetic Engineering Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Genetic Engineering Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Genetic Engineering Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Genetic Engineering Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Genetic Engineering Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Genetic Engineering Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Genetic Engineering Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Genetic Engineering Drug Sales (K Units) by Type (2018-2024)
Table 51. Global Genetic Engineering Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Genetic Engineering Drug Sales Market Share by Type (2018-2024)
Table 53. Global Genetic Engineering Drug Sales Market Share by Type (2024-2029)
Table 54. Global Genetic Engineering Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Genetic Engineering Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Genetic Engineering Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Genetic Engineering Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Genetic Engineering Drug Price (USD/Unit) by Type (2018-2024)
Table 59. Global Genetic Engineering Drug Price (USD/Unit) by Type (2024-2029)
Table 60. Global Genetic Engineering Drug Sales (K Units) by Application (2018-2024)
Table 61. Global Genetic Engineering Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Genetic Engineering Drug Sales Market Share by Application (2018-2024)
Table 63. Global Genetic Engineering Drug Sales Market Share by Application (2024-2029)
Table 64. Global Genetic Engineering Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Genetic Engineering Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Genetic Engineering Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Genetic Engineering Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Genetic Engineering Drug Price (USD/Unit) by Application (2018-2024)
Table 69. Global Genetic Engineering Drug Price (USD/Unit) by Application (2024-2029)
Table 70. Shanghai Lansheng Guojian Pharmaceutical Corporation Information
Table 71. Shanghai Lansheng Guojian Pharmaceutical Description and Business Overview
Table 72. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product
Table 74. Shanghai Lansheng Guojian Pharmaceutical Recent Developments/Updates
Table 75. Biotech Pharmaceutical Corporation Information
Table 76. Biotech Pharmaceutical Description and Business Overview
Table 77. Biotech Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Biotech Pharmaceutical Genetic Engineering Drug Product
Table 79. Biotech Pharmaceutical Recent Developments/Updates
Table 80. Anhui Anke Biotechnology Corporation Information
Table 81. Anhui Anke Biotechnology Description and Business Overview
Table 82. Anhui Anke Biotechnology Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Anhui Anke Biotechnology Genetic Engineering Drug Product
Table 84. Anhui Anke Biotechnology Recent Developments/Updates
Table 85. GeneScience Pharmaceuticals Corporation Information
Table 86. GeneScience Pharmaceuticals Description and Business Overview
Table 87. GeneScience Pharmaceuticals Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. GeneScience Pharmaceuticals Genetic Engineering Drug Product
Table 89. GeneScience Pharmaceuticals Recent Developments/Updates
Table 90. Beijing SL Pharmaceutical Corporation Information
Table 91. Beijing SL Pharmaceutical Description and Business Overview
Table 92. Beijing SL Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Beijing SL Pharmaceutical Genetic Engineering Drug Product
Table 94. Beijing SL Pharmaceutical Recent Developments/Updates
Table 95. Jiangsu Sihuan Bioengineering Corporation Information
Table 96. Jiangsu Sihuan Bioengineering Description and Business Overview
Table 97. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product
Table 99. Jiangsu Sihuan Bioengineering Recent Developments/Updates
Table 100. Shenzhen Neptunus Interlong Bio-Technique Corporation Information
Table 101. Shenzhen Neptunus Interlong Bio-Technique Description and Business Overview
Table 102. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product
Table 104. Shenzhen Neptunus Interlong Bio-Technique Recent Developments/Updates
Table 105. 3SBio Corporation Information
Table 106. 3SBio Description and Business Overview
Table 107. 3SBio Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. 3SBio Genetic Engineering Drug Product
Table 109. 3SBio Recent Developments/Updates
Table 110. Tonghua Dongbao Pharmaceutical Corporation Information
Table 111. Tonghua Dongbao Pharmaceutical Description and Business Overview
Table 112. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product
Table 114. Tonghua Dongbao Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Genetic Engineering Drug Distributors List
Table 118. Genetic Engineering Drug Customers List
Table 119. Genetic Engineering Drug Market Trends
Table 120. Genetic Engineering Drug Market Drivers
Table 121. Genetic Engineering Drug Market Challenges
Table 122. Genetic Engineering Drug Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Genetic Engineering Drug
Figure 2. Global Genetic Engineering Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Genetic Engineering Drug Market Share by Type in 2022 & 2029
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Recombinant Human Erythropoietin Product Picture
Figure 6. Recombinant Human Interferon Product Picture
Figure 7. Recombinant Human Growth Hormone Product Picture
Figure 8. Recombinant Human Insulin Product Picture
Figure 9. Global Genetic Engineering Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Genetic Engineering Drug Market Share by Application in 2022 & 2029
Figure 11. Medicine
Figure 12. Research
Figure 13. Industrial
Figure 14. Agriculture
Figure 15. Other
Figure 16. Global Genetic Engineering Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Genetic Engineering Drug Market Size (2018-2029) & (US$ Million)
Figure 18. Global Genetic Engineering Drug Sales (2018-2029) & (K Units)
Figure 19. Global Genetic Engineering Drug Average Price (USD/Unit) & (2018-2029)
Figure 20. Genetic Engineering Drug Report Years Considered
Figure 21. Genetic Engineering Drug Sales Share by Manufacturers in 2022
Figure 22. Global Genetic Engineering Drug Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Genetic Engineering Drug Players: Market Share by Revenue in 2022
Figure 24. Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Genetic Engineering Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. North America Genetic Engineering Drug Sales Market Share by Country (2018-2029)
Figure 27. North America Genetic Engineering Drug Revenue Market Share by Country (2018-2029)
Figure 28. U.S. Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Genetic Engineering Drug Sales Market Share by Country (2018-2029)
Figure 31. Europe Genetic Engineering Drug Revenue Market Share by Country (2018-2029)
Figure 32. Germany Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Genetic Engineering Drug Sales Market Share by Region (2018-2029)
Figure 38. Asia Pacific Genetic Engineering Drug Revenue Market Share by Region (2018-2029)
Figure 39. China Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Taiwan Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Philippines Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Genetic Engineering Drug Sales Market Share by Country (2018-2029)
Figure 50. Latin America Genetic Engineering Drug Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Genetic Engineering Drug Sales Market Share by Country (2018-2029)
Figure 55. Middle East & Africa Genetic Engineering Drug Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. U.A.E Genetic Engineering Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Sales Market Share of Genetic Engineering Drug by Type (2018-2029)
Figure 60. Global Revenue Market Share of Genetic Engineering Drug by Type (2018-2029)
Figure 61. Global Genetic Engineering Drug Price (USD/Unit) by Type (2018-2029)
Figure 62. Global Sales Market Share of Genetic Engineering Drug by Application (2018-2029)
Figure 63. Global Revenue Market Share of Genetic Engineering Drug by Application (2018-2029)
Figure 64. Global Genetic Engineering Drug Price (USD/Unit) by Application (2018-2029)
Figure 65. Genetic Engineering Drug Value Chain
Figure 66. Genetic Engineering Drug Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed